Insiders · Profile

Pearce Samantha

EVP, Chief Commercial Officer at Jazz Pharmaceuticals. Filing since 8 Jun 2022. CIK 0001805688

Company

Date

Role

Action

Shares

Amount

Of holding

JAZZ Jazz Pharmaceuticals plc

28 May 2026

EVP, Chief Commercial Officer

Sold at will

6,907

$1.63M

12.1%

JAZZ Jazz Pharmaceuticals plc

2 Feb 2023

SVP, Head of Europe & Internat

Sold, plan not stated

531

$83.51K

4.5%

JAZZ Jazz Pharmaceuticals plc

3 Jan 2023

SVP, Head of Europe & Internat

Sold, plan not stated

531

$84.74K

4.5%

JAZZ Jazz Pharmaceuticals plc

13 Dec 2022

SVP, Head of Europe & Internat

Sold, plan not stated

531

$82.54K

4.5%

JAZZ Jazz Pharmaceuticals plc

10 Nov 2022

SVP, Head of Europe & Internat

Sold, plan not stated

1,063

$164.77K

8.6%

JAZZ Jazz Pharmaceuticals plc

2 Sep 2022

SVP, Head of Europe & Internat

Sold, plan not stated

531

$83.36K

4.5%

JAZZ Jazz Pharmaceuticals plc

4 Aug 2022

SVP, Head of Europe & Internat

Sold, plan not stated

531

$82.31K

4.5%

JAZZ Jazz Pharmaceuticals plc

12 Jul 2022

SVP, Head of Europe & Internat

Sold, plan not stated

532

$82.46K

4.5%

JAZZ Jazz Pharmaceuticals plc

27 Jun 2022

SVP, Head of Europe & Internat

Sold, plan not stated

8,508

$1.32M

42.9%

JAZZ Jazz Pharmaceuticals plc

8 Jun 2022

SVP, Head of Europe & Internat

Sold, plan not stated

8,487

$1.32M

42.9%

10 decisions on file.